Three Orphan Drug Program problems and how the FDA plans to fix them
Recently, FDA Commissioner Scott Gottlieb announced the FDA will move to close loopholes in the Orphan Drug Program. Here’s what you need to know.
Read More
Top factors that predict 30-day COPD readmissions
Recent study findings reveal which patients are more likely to be readmitted for COPD problems, and which readmission reduction strategies might work best.
Five ways health executives can impact the opioid crisis
Consider these five opportunities to help curb one of the biggest public health issues of the year.
COPD one of ‘most important’ diagnoses to manage in ACOs
To succeed as a Next Generation ACO, Indiana University Health system is changing its COPD care management approach.
Do antidepressants take more lives than they save?
An eye-opening Canadian study has surprising findings about the risk of death and antidepressants.
Pop health can decrease hypertension, diabetes: 3 takeaways
San Diego-area healthcare organizations experience promising results after using population health strategies to improve hypertension treatment across the region.
Health plan addresses urban vs. rural healthcare disparities
The access problems many rural health plan members face cannot be rectified overnight, but resources, creativity and time can bring these populations up to par with their more urban counterparts.
Payments to specialists could yo-yo under MIPS
Avalere conducted an analysis to assess the effect of MIPS. Here are the surprising results.
Four things payers need to know about acute myeloid leukemia
Physicians need to be able to move quickly to care for patients with AML, and they need to have payers on board.
Six ways to reduce hospital readmissions in 2018
Learn from hospitals and managed care organizations at the forefront of successful initiatives. Read more.
Top ways payers, providers use tech to improve care
How payers, providers are improving work flows, patient care, and cutting costs.
Six policy topics every healthcare executive needs to understand
New healthcare terms and topics constantly crop up. Here are six to keep an eye on right now.
New drug offers hope to advanced breast cancer patients
FDA approved a new treatment for certain breast cancer patients who are not responding to treatment.
Novel device helps diabetics avoid stress linked to glucose testing
FDA approved the first continuous glucose monitoring system that allows for diabetes treatment decisions without requiring a fingerstick.
How to meet unique health needs of LGBT individuals
Finding ways to communicate directly with and provide tailored services to LGBT individuals has been a challenge for managed care organizations, but experts say breaking barriers is imperative.
Pediatric drug market poised for growth
More support for clinical trials and a wider lens for rare diseases in children sets the category on fire.
Two opioid use disorder drug developments to watch
New physician-administered therapies on the horizon may help rein in the opioid epidemic.
Food stamp program participation could impact health costs
A new study reveals how participation in the Supplemental Nutritional Assistance Program could impact healthcare costs for low-income individuals.
Three reasons why maternal mortality rates are rising
Between 1990 and 2013, the maternal mortality ratio more than doubled in the United States. Find out what experts say can resolve the issue.
ACA repeal failure: 5 action items for healthcare execs
Now that the Graham-Cassidy bill has failed, here’s what healthcare executives should do to plan for 2018.
Are ACA repeal efforts over? Experts weigh in
In the wake of the failure of the Graham-Cassidy bill, experts share what’s ahead for health policy.
Beta blockers not needed for heart attack survivors taking these drugs
A new study has shocking results about beta blocker use in heart-attack survivors.
Five ways health plans can encourage telemedicine use
A new HealthMine survey sheds light on how payers can better connect Medicare members to their health plan.
Cholesterol drug misbranded, company pleads guilty
Pharma maker pleads guilty that one of its major drugs was misbranded in a federal court case brought by FDA and the US Department of Justice.
FDA approves generic Tamiflu, plus 2 other new drugs
FDA approved the first generic version of oseltamivir phosphate (Tamiflu, Roche) for oral suspension to treat influenza A and B, plus 2 other noteworthy therapies.
FDA alters stance on opioid addiction drugs
FDA is advising that these 2 opioid addiction medications should not be withheld from patients taking benzodiazepines or other drugs that depress the central nervous system.
Five key findings from health executive value-based care survey
A survey from HealthScape Advisors and the Health Plan Alliance has revealing findings about value-based payment models.
Five rules for payer success in oncology
Payers must reinvent efforts to reduce cancer cost and increase quality for a value-based care world. Here’s five rules to follow.
Top 10 states with the highest uninsured rate
Here are the top 10 states with the highest uninsured rate, according to personal-finance website WalletHub.
Top online resources patients are using to aid in healthcare
A poll by Morning Consult on behalf of University of Phoenix, has revealing results about online health resources.
